MGMT and central nervous system cancer: Some data have suggested that glioblastoma patients harboring MGMT methylation have a different prognosis depending on TERT promoter mutation status [16]; on the other hand, some studies have reported no association in the co-occurrence of TERT promoter mutation and MGMT methylation in glioma patients [14, 17–19].